← Leaderboards
Stephen M Black
Florida International University
$43,557,629
Attributed
$46,698,444
Total exposure
44
Grants
43
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.4M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$79,169,846 · 47
By mechanism
P01$56,903,839 · 35
R01$20,509,745 · 9
UG3$816,988 · 1
R61$516,250 · 1
R21$423,024 · 1
Top collaborators
- Jeffrey R Fineman4 shared
- Heidi M. Mansour4 shared
- Evgeny A. Zemskov4 shared
- Xuexia Wang1 shared
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungMediatingSignal TransductionAttenuatedBlood VesselsProteinsPhosphorylationGenerationsMolecularEndothelial CellsIn VivoPlayEndotheliumRegulationChildBaseNitrationBlood FlowLinkResponseLeadIn VitroMitochondriaEvent
Grant awards (150)
METABOLIC REPROGRAMMING AND PULMONARY VASCULAR DISEASE ASSOCIATED WITH CONGENITAL HEART DISEASE RESULTING IN INCREASED PULMONARY BLOOD FLOW$2,342,524
P01 · FY2025 · HL · contact PI
Mito-inflammation and sepsis-induced acute lung injury$694,398
R01 · FY2025 · HL · contact PI
Metabolic reprogramming of smooth muscle cells in pulmonary hypertension$641,728
R01 · FY2025 · HL · contact PI
Development of Novel RhoA Nitration Inhibitory Peptides for the Treatment of Acute Lung Injury$516,250
R61 · FY2025 · HL · contact PI
Mitochondrial pp60Src and cellular metabolism in pulmonary vascular disease associated with CHD$444,926
P01 · FY2025 · HL · contact PI
TGF-Ã-SOX18-Collagen metabolism in pulmonary vascular disease associated with CHD$425,422
P01 · FY2025 · HL · contact PI
Mitochondrial Imaging, PTM Analysis & Metabolism Core$351,433
P01 · FY2025 · HL · contact PI
Administrative Core$142,624
P01 · FY2025 · HL · contact PI
Administrative Core$2,308,269
P01 · FY2024 · HL · contact PI
Metabolic Reprogramming and Pulmonary Vascular Disease in Congenital Heart Disease$2,308,269
P01 · FY2024 · HL · contact PI
FIU-Diversity Center for Genomic Research (FIU-DCGR)$816,988
UG3 · FY2024 · HG
Metabolic reprogramming of smooth muscle cells in pulmonary hypertension$628,894
R01 · FY2024 · HL · contact PI
Metabolic Reprogramming and Pulmonary Vascular Disease in Congenital Heart Disease$2,379,184
P01 · FY2023 · HL · contact PI
Metabolic reprogramming of smooth muscle cells in pulmonary hypertension$641,728
R01 · FY2023 · HL · contact PI
Post-translational modifications & mitochondrial bioenergetics$434,182
P01 · FY2023 · HL · contact PI
Mitochondrial Imaging, PTM Analysis and Metabolism Core$331,695
P01 · FY2023 · HL · contact PI
Administrative Core$117,115
P01 · FY2023 · HL · contact PI
Metabolic Reprogramming and Pulmonary Vascular Disease in Congenital Heart Disease$2,402,459
P01 · FY2022 · HL · contact PI
Genetics, Epigenetics, and Post-translational Modifications and the Development of Ventilator Induced Lung Injury (VILI)$2,258,774
P01 · FY2022 · HL · contact PI
Project-002$492,419
P01 · FY2022 · HL · contact PI
Project-003$469,193
P01 · FY2022 · HL · contact PI
7985-001 (Project 1)$432,056
P01 · FY2022 · HL · contact PI
Post-translational modifications & mitochondrial bioenergetics$406,959
P01 · FY2022 · HL · contact PI
Mitochondrial Imaging, PTM Analysis and Metabolism Core$316,934
P01 · FY2022 · HL · contact PI
Core-003$304,603
P01 · FY2022 · HL · contact PI
Core-001$252,420
P01 · FY2022 · HL · contact PI
Admin-Core-001$177,168
P01 · FY2022 · HL · contact PI
Core-004$130,915
P01 · FY2022 · HL · contact PI
Administrative Core$127,594
P01 · FY2022 · HL · contact PI
Metabolic Reprogramming and Pulmonary Vascular Disease in Congenital Heart Disease$2,366,426
P01 · FY2021 · HL · contact PI
Genetics, Epigenetics, and Post-translational Modifications and the Development of Ventilator Induced Lung Injury (VILI)$2,080,830
P01 · FY2021 · HL · contact PI
Core-002$687,545
P01 · FY2021 · HL · contact PI
PKG Signaling and Sepsis Induced ALI$450,487
R01 · FY2021 · HL · contact PI
Dysregulation of the NFkB/Sox18 Axis During Ventilator-Induced Lung Injury (VILI)$433,530
P01 · FY2021 · HL · contact PI
Post-translational modifications & mitochondrial bioenergetics$406,959
P01 · FY2021 · HL · contact PI
Project-003$406,699
P01 · FY2021 · HL · contact PI
Project-003$404,135
P01 · FY2021 · HL · contact PI
Project-002$387,179
P01 · FY2021 · HL · contact PI
Project-002$357,315
P01 · FY2021 · HL · contact PI
Core-001$330,279
P01 · FY2021 · HL · contact PI
Mitochondrial Imaging, PTM Analysis and Metabolism Core$316,934
P01 · FY2021 · HL · contact PI
Core-003$274,794
P01 · FY2021 · HL · contact PI
Genetics, Epigenetics, and Post-translational Modifications and the Development of Ventilator-Induced Lung Injury (VILI)$244,693
P01 · FY2021 · HL · contact PI
Core-001$230,367
P01 · FY2021 · HL · contact PI
Protein Chemistry & Biophysics Core$192,029
P01 · FY2021 · HL · contact PI
Core-004$181,462
P01 · FY2021 · HL · contact PI
Administrative Core$177,260
P01 · FY2021 · HL · contact PI
Admin-Core-001$171,913
P01 · FY2021 · HL · contact PI
Admin Core A$138,152
P01 · FY2021 · HL · contact PI
Admin-Core-001$132,237
P01 · FY2021 · HL · contact PI
Metabolic Reprogramming and Pulmonary Vascular Disease in Congenital Heart Disease$2,418,405
P01 · FY2020 · HL · contact PI
Genetics, Epigenetics, and Post-translational Modifications and the Development of Ventilator-Induced Lung Injury (VILI)$2,325,523
P01 · FY2020 · HL · contact PI
Perinatal NO signaling in congenital heart disease$682,425
R01 · FY2020 · HL
Dysregulation of the NFkB/Sox18 Axis During Ventilator-Induced Lung Injury (VILI)$481,700
P01 · FY2020 · HL · contact PI
PKG Signaling and Sepsis Induced ALI$450,487
R01 · FY2020 · HL · contact PI
Post-translational modifications & mitochondrial bioenergetics$406,959
P01 · FY2020 · HL · contact PI
Mitochondrial Imaging, PTM Analysis and Metabolism Core$330,309
P01 · FY2020 · HL · contact PI
Protein Chemistry & Biophysics Core$213,365
P01 · FY2020 · HL · contact PI
Administrative Core$177,260
P01 · FY2020 · HL · contact PI
Admin Core A$153,500
P01 · FY2020 · HL · contact PI
Genetics, Epigenetics, and Post-translational Modifications and the Development of Ventilator-Induced Lung Injury (VILI)$2,325,523
P01 · FY2019 · HL · contact PI
Perinatal NO signaling in congenital heart disease$682,425
R01 · FY2019 · HL · contact PI
Dysregulation of the NFkB/Sox18 Axis During Ventilator-Induced Lung Injury (VILI)$481,700
P01 · FY2019 · HL · contact PI
PKG Signaling and Sepsis Induced ALI$450,487
R01 · FY2019 · HL · contact PI
Protein Chemistry & Biophysics Core$213,365
P01 · FY2019 · HL · contact PI
Admin Core A$153,500
P01 · FY2019 · HL · contact PI
Genetics, Epigenetics, and Post-translational Modifications and the Development of Ventilator-Induced Lung Injury (VILI)$2,325,523
P01 · FY2018 · HL · contact PI
Perinatal NO signaling in congenital heart disease$682,425
R01 · FY2018 · HL · contact PI
Dysregulation of the NFkB/Sox18 Axis During Ventilator-Induced Lung Injury (VILI)$481,700
P01 · FY2018 · HL · contact PI
PKG Signaling and Sepsis Induced ALI$463,862
R01 · FY2018 · HL · contact PI
Protein Chemistry & Biophysics Core$213,365
P01 · FY2018 · HL · contact PI
Admin Core A$153,500
P01 · FY2018 · HL · contact PI
Perinatal NO signaling in congenital heart disease$689,715
R01 · FY2017 · HL · contact PI
Perinatal Regulation of Endothelial NOS$535,517
R01 · FY2017 · HL · contact PI
Perinatal Regulation of Endothelial NOS$536,868
R01 · FY2016 · HL · contact PI
Human Tissue & Animal Core Unit$390,000
P01 · FY2016 · HL · contact PI
Role of Protein Nitration In Altering The Rho/Rac1 Balance In Acute Lung Injury$364,609
P01 · FY2016 · HL · contact PI
Therapeutic Mechanisms of RhoA Inhibition In Acute Lung Injury$352,499
P01 · FY2016 · HL · contact PI
Modulation eNOS Coupling In Gram Positive Infection-Associated Acute Lung Injury$352,497
P01 · FY2016 · HL · contact PI
Analytical Core Unit$324,430
P01 · FY2016 · HL · contact PI
Rac1 Stimulation in Adenosine-Induced Barrier Protection$311,897
P01 · FY2016 · HL · contact PI
Administrative Core Unit$176,568
P01 · FY2016 · HL · contact PI
Perinatal Regulation of Endothelial NOS$528,815
R01 · FY2015 · HL · contact PI
Human Tissue & Animal Core Unit$384,148
P01 · FY2015 · HL · contact PI
Role of Protein Nitration In Altering The Rho/Rac1 Balance In Acute Lung Injury$359,138
P01 · FY2015 · HL · contact PI
Therapeutic Mechanisms of RhoA Inhibition In Acute Lung Injury$347,214
P01 · FY2015 · HL · contact PI
Modulation eNOS Coupling In Gram Positive Infection-Associated Acute Lung Injury$347,212
P01 · FY2015 · HL · contact PI
Analytical Core Unit$319,563
P01 · FY2015 · HL · contact PI
Rac1 Stimulation in Adenosine-Induced Barrier Protection$307,220
P01 · FY2015 · HL · contact PI
Administrative Core Unit$173,917
P01 · FY2015 · HL · contact PI
Perinatal Regulation of Endothelial NOS$547,145
R01 · FY2014 · HL · contact PI
Endothelial Barrier Protection and Repair in Acute Lung Injury$2,163,419
P01 · FY2013 · HL · contact PI
Human Tissue & Animal Core Unit$371,279
P01 · FY2013 · HL · contact PI
Role of Protein Nitration In Altering The Rho/Rac1 Balance In Acute Lung Injury$347,103
P01 · FY2013 · HL · contact PI
Modulation eNOS Coupling In Gram Positive Infection-Associated Acute Lung Injury$335,580
P01 · FY2013 · HL · contact PI
Therapeutic Mechanisms of RhoA Inhibition In Acute Lung Injury$335,580
P01 · FY2013 · HL · contact PI
Analytical Core Unit$308,858
P01 · FY2013 · HL · contact PI
Rac1 Stimulation in Adenosine-Induced Barrier Protection$296,927
P01 · FY2013 · HL · contact PI
Administrative Core Unit$168,092
P01 · FY2013 · HL · contact PI
Endothelial Barrier Protection and Repair in Acute Lung Injury$2,272,500
P01 · FY2012 · HL · contact PI
Role of Protein Nitration In Altering The Rho/Rac1 Balance In Acute Lung Injury$364,603
P01 · FY2012 · HL · contact PI
Analytical Core Unit$324,432
P01 · FY2012 · HL · contact PI
Administrative Core Unit$176,568
P01 · FY2012 · HL · contact PI
Endothelial Barrier Protection and Repair in Acute Lung Injury$2,257,350
P01 · FY2011 · HL · contact PI
ROS in Pulmonary Hypertension: Role of ADMA$369,118
R01 · FY2011 · HL · contact PI
Role of Protein Nitration In Altering The Rho/Rac1 Balance In Acute Lung Injury$362,173
P01 · FY2011 · HL · contact PI
Administrative Core Unit$175,391
P01 · FY2011 · HL · contact PI
Perinatal Regulation of Endothelial NOS$488,308
R01 · FY2010 · HL · contact PI
Perinatal regulation of TGF-beta1 during vascular remodeling$369,834
R01 · FY2010 · HL · contact PI
ROS in Pulmonary Hypertension: Role of ADMA$369,118
R01 · FY2010 · HL · contact PI
Role of Neuronal NOS in Neurotoxicity$292,548
R01 · FY2010 · HD · contact PI
Perinatal Regulation of Endothelial NOS$488,871
R01 · FY2009 · HL · contact PI
Perinatal regulation of TGF-beta1 during vascular remodeling$370,268
R01 · FY2009 · HL · contact PI
ROS in Pulmonary Hypertension: Role of ADMA$369,118
R01 · FY2009 · HL · contact PI
Role of Neuronal NOS in Neurotoxicity$297,081
R01 · FY2009 · HD · contact PI
Role of altered carnitine metabolism in perinatal endothelial dysfunction$224,687
R21 · FY2009 · HD · contact PI
ROS in Pulmonary Hypertension: Role of ADMA$392,618
R01 · FY2008 · HL · contact PI
Perinatal regulation of TGF-beta1 during vascular remodeling$370,628
R01 · FY2008 · HL · contact PI
Role of Neuronal NOS in Neurotoxicity$297,215
R01 · FY2008 · HD · contact PI
Role of altered carnitine metabolism in perinatal endothelial dysfunction$198,337
R21 · FY2008 · HD · contact PI
Perinatal regulation of TGF-beta1 during vascular remodeling$383,789
R01 · FY2007 · HL · contact PI
Perinatal regulation of endothelial NOS$312,989
R01 · FY2007 · HL · contact PI
Role of Neuronal NOS in Neurotoxicity$270,686
R01 · FY2007 · HD · contact PI
NO-mediated signaling in endothelial cells$321,326
R01 · FY2006 · HL · contact PI
Role of Neuronal NOS in Neurotoxicity$283,348
R01 · FY2006 · HD · contact PI
ENOS Dimer Disruption and Endothelial Dysfunction$275,779
R01 · FY2006 · HL · contact PI
Perinatal regulation of endothelial NOS$214,586
R01 · FY2006 · HL · contact PI
Perinatal regulation of endothelial NOS$95,209
R01 · FY2006 · HL · contact PI
NO-mediated signaling in endothelial cells$70,892
R01 · FY2006 · HL · contact PI
ENOS Dimer Disruption and Endothelial Dysfunction$1
R01 · FY2006 · HL · contact PI
NO-mediated signaling in endothelial cells$389,961
R01 · FY2005 · HL
Perinatal regulation of endothelial NOS$315,938
R01 · FY2005 · HL
ENOS Dimer Disruption and Endothelial Dysfunction$280,834
R01 · FY2005 · HL
Reactive Oxygen Species in PPHN$146,500
R01 · FY2005 · HL
Reactive Oxygen Species in PPHN$133,500
R01 · FY2005 · HL
NO-mediated signaling in endothelial cells$378,602
R01 · FY2004 · HL
Perinatal regulation of endothelial NOS$315,000
R01 · FY2004 · HL
ENOS Dimer Disruption and Endothelial Dysfunction$280,000
R01 · FY2004 · HL
Reactive Oxygen Species in PPHN$280,000
R01 · FY2004 · HL
NO-mediated signaling in endothelial cells$398,330
R01 · FY2003 · HL
ENOS Dimer Disruption and Endothelial Dysfunction$301,245
R01 · FY2003 · HL
Reactive Oxygen Species in PPHN$222,553
R01 · FY2003 · HL
Reactive Oxygen Species in PPHN$42,728
R01 · FY2003 · HL
Reactive Oxygen Species in PPHN$260,367
R01 · FY2002 · HL
THE ROLE OF NEURONAL NOS DIMERIZATION IN NEUROTOXICITY$122,879
R01 · FY2002 · HD
THE ROLE OF NEURONAL NOS DIMERIZATION IN NEUROTOXICITY$63,692
R01 · FY2002 · HD
THE ROLE OF NEURONAL NOS DIMERIZATION IN NEUROTOXICITY$181,137
R01 · FY2001 · HD
PERINATAL REGULATION OF THE ENDOTHELIAL NOS GENE$106,763
R01 · FY2001 · HL
THE ROLE OF NEURONAL NOS DIMERIZATION IN NEUROTOXICITY$175,860
R01 · FY2000 · HD
PERINATAL REGULATION OF THE ENDOTHELIAL NOS GENE$103,120
R01 · FY2000 · HL